Europe and Israel Mobile Applications for Melanoma Detection Market: Snapshot

Melanoma is primarily linked to prolonged exposure to UV radiation during childhood and this preventable skin condition has been on a rise in recent years. A significant spike in the incidence rate of melanoma has driven the need for effective and swift detection tools and techniques. Early detection of melanoma is crucial for improved prognosis and this can be achieved by skin surveillance and screening. This growing need, coupled with an increase in efforts to improve the awareness levels about this skin condition, has spurred the trend of early diagnosis. This has, in turn, driven the demand for mobile applications used for the detection of melanoma in Europe as well as Israel.

Impressive Performance of Greece Market despite Economic Volatility

Regionally, the market for mobile applications for melanoma detection is split into Europe and Israel. Europe accounts for the dominant share and the opportunity in this market is slated to be worth US$1.4 mn by 2022. While the mobile application market for melanoma detection in Europe is fueled by the surge in mHealth trends and rising incidence of melanoma, it is significantly driven by the performance of the market in Greece.

Despite the economic volatility in Greece, the market for mobile applications for melanoma detection will continue to witness growth owing to the development of eHealth infrastructure in the country and rising number of melanoma cases. Growing smartphone penetration is also a key factor driving the Greece market for mobile applications for melanoma detection. In addition to this, a high doctor-patient ratio has enabled the establishment of a strong network of doctors dedicated toward the detection of melanoma through mobile health services.

The Rest of Europe comprises several key markets for mobile applications for melanoma detection: Switzerland, Denmark, the Netherlands, the U.K., Norway, and Sweden. High internet and smartphone penetration and rising incidence rate and mortality rate of melanoma are the major growth boosters.

Strong Penetration of Smartphones and Expanding 3G, 4G Networks Supporting Market in Israel

Israel is anticipated to witness impressive growth during the forecast period, exhibiting a 61.2% CAGR from 2014 to 2022. The rising prevalence of melanoma has been the primary driving factor in this region, especially based on information provided by the Israel Cancer Association. The organization states that in 2012 alone, nearly 1,300 new cases of malignant melanoma were reported in the country. This has resulted in increasing awareness among the general population regarding self-screening and early detection of cancer.

Rapid expansion of 3G and 4G networks and several government initiatives have also supported the development of the mobile applications market for melanoma detection in Israel. Google Inc.’s research titled ‘Our Mobile Planet’ finds that the smartphone penetration rate in the country crossed 56.0% in 2013. These factors are slated to drive the regional market to reach a value of US$77,765.3 by 2022.

Some of the leading mobile applications for melanoma detection in Europe and Israel are Dermatology Planet, UMSkinCheck, Mole Check, Skin Tagger, Track-A-Mole, SkinVision, Spot Mole, Skin Scanner, NÄ“vus, SpotCheck, Mole Monitor, Mole Checker, Mole Checker/Stroika, FotoSKin, Melanoma Watch, Skin Mole Analysis, YourSkinDiary, OnlineDermClinic, Dr. Mole, Mollie’s Fund, MoleQuest, Skin Analytics, Spot Mole Plus, Skin Cancer, Skin Doctor, Skin Of Mine, iSkin, MoleTrac, Mole Doctor, Skin Prevention, and LovemySkin.